ZARS Expands Board

Salt Lake City, Utah-based ZARS Pharma announced Monday that it has added two new people to its board of directors. Robert Lippert, the firm's President and CEO, and Lynn DeBry have joined the firm's board. DeBry is a retired partner at KPMG LLP, and has served on the boards of First USA Financial Services, Inc., Utah Technologies Association, Wayne Brown Institute and Utah Boys' Ranch. Lippert has been at the firm since 2003. ZARS is developing patch-based drug delivery technology, and has seen funding from companies such as Draper Fisher Jurvetson, CDIB, Wasatch Venture Fund, and others. More information »